Femme Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
To investigate if tranexamic acid and/or mefenamic acid are superior to placebo in the management of bleeding/spotting during the first 90 days of levonorgestrel-releasing intrauterine system use.
Critère d'inclusion
- Management of bleeding/spotting in women using the levonorgestrel-releasing intrauterine system (Mirena) for contraception